SCRIB and neoplasm: Deregulation of these proteins has been shown in a number of human epithelial cancers: mislocalized and deregulated hScrib expression is seen in colorectal [28], breast [29], prostate [30], and endometrial cancers [31], providing further powerful evidence supporting a role for these proteins in tumor suppression.